ATE250056T1 - Heteroaryl protease inhibitoren und diagnostische bilderzeugungsmittel - Google Patents

Heteroaryl protease inhibitoren und diagnostische bilderzeugungsmittel

Info

Publication number
ATE250056T1
ATE250056T1 AT00960130T AT00960130T ATE250056T1 AT E250056 T1 ATE250056 T1 AT E250056T1 AT 00960130 T AT00960130 T AT 00960130T AT 00960130 T AT00960130 T AT 00960130T AT E250056 T1 ATE250056 T1 AT E250056T1
Authority
AT
Austria
Prior art keywords
blood
compounds
inhibiting
formation
thrombin
Prior art date
Application number
AT00960130T
Other languages
English (en)
Inventor
Wenxi Pan
Tianbao Lu
Richard M Soll
Bruce E Tomczuk
Original Assignee
Dimensional Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dimensional Pharm Inc filed Critical Dimensional Pharm Inc
Application granted granted Critical
Publication of ATE250056T1 publication Critical patent/ATE250056T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/76—Nitrogen atoms to which a second hetero atom is attached
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00960130T 1999-07-09 2000-07-07 Heteroaryl protease inhibitoren und diagnostische bilderzeugungsmittel ATE250056T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14292999P 1999-07-09 1999-07-09
PCT/US2000/040332 WO2001004117A1 (en) 1999-07-09 2000-07-07 Heteroaryl protease inhibitors and diagnostic imaging agents

Publications (1)

Publication Number Publication Date
ATE250056T1 true ATE250056T1 (de) 2003-10-15

Family

ID=22501854

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00960130T ATE250056T1 (de) 1999-07-09 2000-07-07 Heteroaryl protease inhibitoren und diagnostische bilderzeugungsmittel

Country Status (6)

Country Link
US (1) US6420397B1 (de)
EP (1) EP1194428B1 (de)
AT (1) ATE250056T1 (de)
CA (1) CA2379416A1 (de)
DE (1) DE60005351D1 (de)
WO (1) WO2001004117A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69836346T2 (de) 1997-11-26 2007-05-24 Ortho-Mcneil Pharmaceutical, Inc. Heteroaryl aminoguanidin- und alkoxyguanidinderivate und ihre verwendung als proteasehemmer
SI21097A (sl) * 2001-12-04 2003-06-30 Univerza V Ljubljani Inhibitorji trombina
US7285287B2 (en) * 2002-11-14 2007-10-23 Synecor, Llc Carbon dioxide-assisted methods of providing biocompatible intraluminal prostheses
US20040098106A1 (en) * 2002-11-14 2004-05-20 Williams Michael S. Intraluminal prostheses and carbon dioxide-assisted methods of impregnating same with pharmacological agents
US6932930B2 (en) * 2003-03-10 2005-08-23 Synecor, Llc Intraluminal prostheses having polymeric material with selectively modified crystallinity and methods of making same
FR2857967B1 (fr) * 2003-07-25 2015-04-24 Centre Nat Rech Scient Complexes de lanthanide, leur preparation et leurs utilisations
US9788539B2 (en) 2011-05-17 2017-10-17 Velico Medical, Inc. Platelet protection solution having beta-galactosidase and sialidase inhibitors
CA2835434A1 (en) 2011-05-17 2012-11-22 Velico Medical, Inc. Improved platelet storage using a sialidase inhibitor
WO2014055988A1 (en) 2012-10-05 2014-04-10 Velico Medical, Inc. Platelet additive solution having a beta-galactosidase inhibitor
WO2014120886A1 (en) 2013-01-30 2014-08-07 Velico Medical, Inc. Platelet additive solution having a self-assembling hydrogel-forming peptide
EP2994174A1 (de) 2013-05-06 2016-03-16 Abbott Cardiovascular Systems Inc. Mit therapeutischer wirkstoffformulierung gefüllter hohler stent

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4418052A (en) 1980-08-12 1983-11-29 Wong Dennis W Diagnostic compositions and method for radiologic imaging of fibrinogen deposition in the body
US4957939A (en) 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
US4727064A (en) 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
US4652440A (en) 1984-05-03 1987-03-24 Paik Chang H Method of stably radiolabeling antibodies with technetium and rhenium
US4980148A (en) 1985-02-06 1990-12-25 Mallinckrodt, Inc. Methods for enhancing magnetic resonance imaging
GB8506792D0 (en) 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
US5011686A (en) 1987-09-21 1991-04-30 Creative Biomolecules, Inc. Thrombus specific conjugates
US5002935A (en) 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
ZA897515B (en) 1988-10-07 1990-06-27 Merrell Dow Pharma Novel peptidase inhibitors
US5024829A (en) 1988-11-21 1991-06-18 Centocor, Inc. Method of imaging coronary thrombi
US5122361A (en) 1989-04-17 1992-06-16 Trustees Of The University Of Pennsylvania Dopamine receptor ligands and imaging agents
EP0604022A1 (de) 1992-12-22 1994-06-29 Advanced Cardiovascular Systems, Inc. Mehrschichtiges resorbierbares Stent und Verfahren zu dessen Herstellung
US5656600A (en) 1993-03-25 1997-08-12 Corvas International, Inc. α-ketoamide derivatives as inhibitors of thrombosis
GB9318637D0 (en) 1993-09-08 1993-10-27 Ferring Res Ltd Enzyme inhibitors
US6087479A (en) 1993-09-17 2000-07-11 Nitromed, Inc. Localized use of nitric oxide-adducts to prevent internal tissue damage
US5466811A (en) 1994-07-18 1995-11-14 Merck & Co., Inc. Dioxolenylmethyl carbamates pro moieties for amine drugs
ES2235174T3 (es) 1994-10-17 2005-07-01 Kabushikikaisha Igaki Iryo Sekkei Stent liberador de medicamento.
US5643580A (en) 1994-10-17 1997-07-01 Surface Genesis, Inc. Biocompatible coating, medical device using the same and methods
US5637113A (en) 1994-12-13 1997-06-10 Advanced Cardiovascular Systems, Inc. Polymer film for wrapping a stent structure
AU693636B2 (en) 1994-12-13 1998-07-02 Corvas International, Inc. Aromatic heterocyclic derivatives as enzyme inhibitors
DE19514104C2 (de) 1995-04-13 1997-05-28 Behringwerke Ag Beschichtung für in den Blutstrom oder in das Gewebe des menschlichen Körpers einbringbares Biomaterial
JPH11508558A (ja) 1995-06-27 1999-07-27 メルク エンド カンパニー インコーポレーテッド ピリジノン トロンビン阻害剤
AU720616B2 (en) 1996-02-22 2000-06-08 Merck & Co., Inc. Pyridinone thrombin inhibitors
WO1997036580A1 (en) 1996-03-29 1997-10-09 3-Dimensional Pharmaceuticals, Inc. Amidinohydrazones as protease inhibitors
WO1998016547A1 (en) * 1996-10-11 1998-04-23 Cor Therapeutics, Inc. SELECTIVE FACTOR Xa INHIBITORS
US5792779A (en) * 1997-02-19 1998-08-11 Merck & Co., Inc. Pyridinone thrombin inhibitors
DE69836346T2 (de) 1997-11-26 2007-05-24 Ortho-Mcneil Pharmaceutical, Inc. Heteroaryl aminoguanidin- und alkoxyguanidinderivate und ihre verwendung als proteasehemmer

Also Published As

Publication number Publication date
EP1194428B1 (de) 2003-09-17
DE60005351D1 (de) 2003-10-23
EP1194428A1 (de) 2002-04-10
WO2001004117A1 (en) 2001-01-18
CA2379416A1 (en) 2001-01-18
US6420397B1 (en) 2002-07-16

Similar Documents

Publication Publication Date Title
WO1998023565A3 (en) Aminoguanidines and alkoxyguanidines as protease inhibitors
DK1086122T3 (da) Pyrazinonproteaseinhibitorer
BR9815325A (pt) Heteroaril, aminoguanidinas e alcóxiguanidinas eseu uso como inibidores da protease
DE60122546D1 (en) Aminopyridinyl-, aminoguanidinyl- und alkoxyguanidinyl- substituierte phenylacetamide als protease inhibitoren
NO20004871D0 (no) Benzamid- og sulfonamid-substituert aminoguanidiner og alkoksyguanidiner som protease inhibitorer
DE60122750D1 (de) Amidine-inhibitoren der serine-proteasen
ATE250056T1 (de) Heteroaryl protease inhibitoren und diagnostische bilderzeugungsmittel
WO2002006248A3 (en) Cyclic oxyguanidine pyrazinones as protease inhibitors
MXPA01008084A (es) Heteroarilamidinas, metilamidinas y guanidinas como inhibidores de proteasa.
TW200508200A (en) Substituted phenyl acetamides and their use as protease inhibitors
MXPA03000963A (es) Inhibidores de oxiguanidina ciclica proteasa.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties